Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency

Fetal Diagnosis and Therapy

Volumn 16, Issue 6, 2001, Pages 360-363

  Mangione, Raphaële ^a   Guyon, Frédéric ^a   Taine, Laurence ^a   Wen, Zong Qi ^a   Roux, Denis ^a   Vergnaud, Armand ^a   Maugey Laulom, Brigitte ^a   Horovitz, Jacques ^a   Saura, Robert ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Chromosomal abnormalities; Fetal abnormalities; Fetal karyotype; Fetal outcome; Genetic syndromes; Nuchal translucency

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYSTIC LYMPHANGIOMA; DIAGNOSTIC VALUE; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS MONITORING; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN DEATH; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; SPONTANEOUS ABORTION; ULTRASOUND;

ADULT; CHROMOSOME ABERRATIONS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; KARYOTYPING; LYMPHANGIOMA, CYSTIC; MATERNAL AGE; NECK; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 0034755585     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053941     Document Type: Article

References (31)

1. Dépistage de la trisomie 21 parmesure de la clarté nucale au premier trimestre de la grossesse
2. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities
3. Dépistage de la trisomie 21 par association des marqueurs biologiques et échographiques
4. Free bhCG as first trimester marker for fetal trisomy
5. First trimester screening for Down's syndrome using maternal serum PAPP-A and free b-hCG in combination with fetal nuchal translucency thickness
6. Efficiency of ultrasound and biochemical markers for Down's syndrome risk screening. A prospective study
7. Fetal heart rate and nuchal translucency in detecting chromosomal abnormalities other than Down syndrome
8. First trimester sonographic detection of chromosomal abnormalities in an unselected population
9. First trimester fetal nuchal translucency thickness and risk for trisomies
10. Screening for fetal trisomies by maternal age and nuchal translucency thickness at 10 to 14 weeks of gestation
11. Increased nuchal translucency as a marker for fetal chromosomal defects
12. First trimester nuchal translucency: A risk analysis on chromosome abnormality
13. Nuchal thickening or cystic hygromas in first and early second-trimester fetuses: Prognosis and outcome
14. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4,233 unselected pregnant women
15. Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy
16. Evaluation of chorion villus sampling
17. Operator experience and fetal loss rate in trans-abdominal chorion villus sampling
18. Fetal nuchal translucency: Ultrasound screening for fetal trisomy in the first trimester of pregnancy
19. Diagnostic préatal des œdèmes de la nuque et des hygromas kystiques du cou
20. First trimester diagnosis of fetal nuchal edema: Report of 29 cases
21. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks'gestation
22. Transvaginal sonography detection of findings suggestive of fetal chromosomal anomalies in the first and early second trimesters
23. Fetal outcome in nuchal translucency with emphasis on normal karyotype
24. Weekly nuchal translucency measurements in normal fetuses
25. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice
26. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
27. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks of gestation
28. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation
29. Diagnosis of fetal abnormalities at the 10-14 week scan
30. Outcome of fetuses with enlarged nuchal translucency and normal karyotype
31. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study